Pulse-to-pulse modulation of transmitter release in the central nervous system. Basic and pharmacological aspects.
Cejna
M
M
Institute of Pharmacology, University of Vienna, Austria.
Agneter
E
E
Drobny
H
H
Valenta
B
B
Singer
E A
EA
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D000068438:Brimonidine Tartrate; D002490:Central Nervous System / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D006706:Homeostasis; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011804:Quinolines / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014316:Tritium / Q000378:metabolism
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D018492:Dopamine Antagonists; D011804:Quinolines; D011810:Quinoxalines; D014316:Tritium; D000068438:Brimonidine Tartrate; C000470:EEDQ; D004298:Dopamine; D009638:Norepinephrine